Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学NSCLC Osimertinib Adjuvant

Enriqueta Felip

MD, PhD

🏢Vall d'Hebron University Hospital🌐Spain

Head, Thoracic Oncology Unit

72
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Enriqueta Felip is a leading European thoracic oncologist who has been a key investigator in adjuvant osimertinib trials and immunotherapy-chemotherapy combinations for NSCLC. Her research spans early-stage and advanced NSCLC with particular expertise in biomarker-guided therapy. She leads the thoracic oncology program at Vall d'Hebron as a European center of excellence.

Share:

🧪Research Fields 研究领域

Lung cancer
Adjuvant therapy
Osimertinib
Immunotherapy
Molecular-driven therapy

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Enriqueta Felip 的研究动态

Follow Enriqueta Felip's research updates

留下邮箱,当我们发布与 Enriqueta Felip(Vall d'Hebron University Hospital)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment